...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Thoughts on ZCC

....what would seem to be heavily discounted financing is at the top of my list.

All depends what you compare them to.  You're comparing to other companies.  I'm comparing to a particular OTC stock.  So the PPs look pretty decent to me.

 

 

 

Share
New Message
Please login to post a reply